Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations
Francesc Castro-Giner, Sofia Gkountela, Cinzia Donato, et al.
Diagnostics (2018) Vol. 8, Iss. 2, pp. 31-31
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
Raffaele Palmirotta, Domenica Lovero, Paola Cafforio, et al.
Therapeutic Advances in Medical Oncology (2018) Vol. 10
Open Access | Times Cited: 379
Tracking cancer progression: from circulating tumor cells to metastasis
Francesc Castro-Giner, Nicola Aceto
Genome Medicine (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 292
ctDNA as a cancer biomarker: A broad overview
Luciana Santos Pessoa, Manoela Heringer, Valéria Pereira Ferrer
Critical Reviews in Oncology/Hematology (2020) Vol. 155, pp. 103109-103109
Open Access | Times Cited: 200
Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs
Giovanna Casagrande, Marcela de Oliveira Silva, Rui Manuel Reis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2505-2505
Open Access | Times Cited: 81
Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology
R. Mathai, Ryali Valli Sri Vidya, Bobby Reddy, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 3, pp. 373-373
Open Access | Times Cited: 121
Glycans as Biomarkers in Prostate Cancer
Emma Scott, Jennifer Munkley
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1389-1389
Open Access | Times Cited: 120
Molecular Pathology of Colorectal Cancer
Shuko Harada, Diana Morlote
Advances in Anatomic Pathology (2019) Vol. 27, Iss. 1, pp. 20-26
Closed Access | Times Cited: 107
Multiple microRNAs as biomarkers for early breast cancer diagnosis
Ji Young Jang, Yeon Mee Kim, Kyung‐Sun Kang, et al.
Molecular and Clinical Oncology (2020) Vol. 14, Iss. 2
Open Access | Times Cited: 95
Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors
Pamela Pinzani, Valeria D’Argenio, Marzia Del Re, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 7, pp. 1181-1200
Open Access | Times Cited: 92
Accurate diagnosis of pulmonary nodules using a noninvasive DNA methylation test
Wenhua Liang, Zhiwei Chen, Caichen Li, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 10
Open Access | Times Cited: 80
Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
Maja Šutić, Ana Vukić, Jurica Baranašić, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 11, pp. 1102-1102
Open Access | Times Cited: 80
Cancer Liquid Biopsy Using Integrated Microfluidic Exosome Analysis Platforms
Guiying Li, Weiwei Tang, Fang Yang
Biotechnology Journal (2020) Vol. 15, Iss. 5
Closed Access | Times Cited: 72
Liquid Biopsy: A Distinctive Approach to the Diagnosis and Prognosis of Cancer
Tetsuyuki Hirahata, Reeshan ul Quraish, Afraz ul Quraish, et al.
Cancer Informatics (2022) Vol. 21
Open Access | Times Cited: 59
Circulating tumour cells in the -omics era: how far are we from achieving the ‘singularity’?
Tanvi H. Visal, Petra den Hollander, Massimo Cristofanilli, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 2, pp. 173-184
Open Access | Times Cited: 51
Toward Personalized Nanomedicine: The Critical Evaluation of Micro and Nanodevices for Cancer Biomarker Analysis in Liquid Biopsy
Kimberley Clack, Narshone Soda, Surasak Kasetsirikul, et al.
Small (2023) Vol. 19, Iss. 15
Open Access | Times Cited: 40
Multi-omics integrated circulating cell-free DNA genomic signatures enhanced the diagnostic performance of early-stage lung cancer and postoperative minimal residual disease
Yun Li, Guanchao Jiang, Wendy Wu, et al.
EBioMedicine (2023) Vol. 91, pp. 104553-104553
Open Access | Times Cited: 31
Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management
Pavol Žúbor, Peter Kubatka, Karol Kajo, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 2878-2878
Open Access | Times Cited: 73
The Liquid Biopsy in the Management of Colorectal Cancer: An Overview
Marco Vacante, Roberto Ciuni, Francesco Basile, et al.
Biomedicines (2020) Vol. 8, Iss. 9, pp. 308-308
Open Access | Times Cited: 60
Microfluidics for Liquid Biopsies: Recent Advances, Current Challenges, and Future Directions
Yuri Belotti, Chwee Teck Lim
Analytical Chemistry (2021) Vol. 93, Iss. 11, pp. 4727-4738
Closed Access | Times Cited: 54
Nanoparticle-based biosensors for detection of extracellular vesicles in liquid biopsies
Beatriz Martín-Gracia, Alba Martín‐Barreiro, Carlos Cuestas-Ayllón, et al.
Journal of Materials Chemistry B (2020) Vol. 8, Iss. 31, pp. 6710-6738
Open Access | Times Cited: 51
2D MOF Nanosensor‐Integrated Digital Droplet Microfluidic Flow Cytometry for In Situ Detection of Multiple miRNAs in Single CTC Cells
Junyue Chen, Gerile Oudeng, Hongtao Feng, et al.
Small (2022) Vol. 18, Iss. 32
Closed Access | Times Cited: 37
Is there an advantage of monitoring via exosome-based detection of EGFR mutations during treatment in non-small cell lung cancer patients?
Ege Rıza Karagür, Aydın Demiray, Nedim Karagenç, et al.
Genetika (2023) Vol. 55, Iss. 1, pp. 83-93
Open Access | Times Cited: 17
Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors
Seyed Mohammad Kazem Aghamir, Ramin Heshmat, Mehdi Ebrahimi, et al.
Epigenetics Insights (2020) Vol. 13
Open Access | Times Cited: 43
Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA
Mohammad Amin Kerachian, Marjan Azghandi, Sina Mozaffari‐Jovin, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 40
Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer
Chiara Guarini, Teresa Grassi, Gaetano Pezzicoli, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6813-6813
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top